Nirvana Super Pro Supplementation in Orthopedic Surgery Patients

Study Purpose

The purpose of this study is to investigate orthopedic patients undergoing either a total hip replacement (THR) or total knee arthroplasty (TKR) using two dietary supplements, PREPARE and RECOVER, and their recovery times post-surgery.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Yes
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 45 Years - 80 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Male and female subjects will be enrolled into the study.
  • - Age ≥45-80 years.
  • - Free of liver and kidney diseases, and with no evidence of uncontrolled hypertension.
  • - Does not have a chronic disease that affects calcium or bone metabolism (i.e., asthma with chronic use of high dose steroids, inflammatory bowel disease, Crohn's disease, primary hyperparathyroidism, seizure disorder with use of phenobarbital, etc.).
  • - Not classified as morbidly obese (body mass index (BMI) >43 kg/m2).
  • - Six weeks since major surgery (three weeks since minor surgery).
  • - Total joint replacement is not a revision of previous joint replacement.
  • - Willing to consume dietary supplements for the study period.
  • - Individuals diagnosed with osteoporosis, or a bone density >2.0 standard deviations below the mean, will not be enrolled in the study.
  • - No other serious medical illness.
  • - Physicians have placed no restriction on physical exercise.
  • - Patient is scheduled for a total knee or hip replacement and agrees to consume the 28-day pre-operative regime.

Exclusion Criteria:

  • - Evidence of liver and kidney diseases, uncontrolled hypertension, or Type I or II diabetes mellitus requiring insulin for glucose control.
  • - The presence of a chronic disease that affects calcium or bone metabolism (i.e., asthma with chronic use of high dose steroids, inflammatory bowel disease, Crohn's disease, primary hyperparathyroidism, seizure disorder with use of phenobarbital, etc.).
  • - Classified as morbidly obese (body mass index (BMI) >43 kg/m2).
  • - Less than six weeks since major surgery or three weeks since minor surgery.
  • - Surgery is a revision of a previous total joint replacement.
  • - Not willing to consume nutritional supplements for the study period.
  • - Individuals diagnosed with osteoporosis, or a bone density >2.0 standard deviations below the mean, will not be enrolled in the study.
  • - Other serious medical illness, which the subject's doctor or medical review team has decided affects the subject's ability to participate in the study.
For example, pathological hip fracture or cancer disease in active phase or undergoing treatment (radiotherapy or chemotherapy).
  • - History of blood clots and/or the use of blood thinning medications.
  • - Subjects on high dose vitamin D therapies (i.e., 50,000 IU vitamin D).

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT06203691
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Super Inspired LLC
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Candice St. Pierre, Ph.D.
Principal Investigator Affiliation Nirvana Water Sciences Corp
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Arthropathy of Knee, Arthropathy of Hip
Study Website: View Trial Website
Additional Details

This study involves two dietary supplements that have been formulated by Nirvana Water Sciences Corp for Super Inspired LLC. A pre-operative supplement, called PREPARE, has been created with HMB, Vitamin D, Selenium, Zinc, and Vitamin C to provide pre-operative nutrition, promote lean muscle development and boost immunity. A post-operative supplement, called RECOVER, has been created with HMB, collagen, L-citrulline, resveratrol, and 2-HOBA to help maintain lean muscle, support wound healing and reduce oxidative stress. HMB or βeta-hydroxy βeta-methylbutyrate is a nutritional supplement that has been extensively studied for its potential benefits. It is a substance that your body naturally produces when it breaks down the amino acid leucine, which is essential for protein synthesis and muscle repair. There are over 50 human studies, 40 review articles and four meta-analyses showing its effectiveness and safety. These clinical studies provide evidence of the benefits of HMB and supports the claims that HMB boosts muscle performance, slows muscle degradation, and reduces muscle recovery time. Muscle atrophy (loss of muscle mass) and poor muscle function are demonstrated in patients suffering from osteoarthritis (OA) involving several joints and particularly the hip and the knee joints. Several studies have shown that this atrophy is worsened in the immediate postoperative period, and complete recovery is not established up to 2 years postop. Little is known about muscular recovery after either total hip replacement (THR) or total knee arthroplasty (TKR).

Arms & Interventions

Arms

Experimental: Supplement Group

50 of the 100 participants will be given supplements (Prepare & Recover) for pre & post operation.

Placebo Comparator: Non-Supplement Group

No supplements will be given to the non-supplement group.

Interventions

Dietary Supplement: - Supplementation with Nirvana Super Pro Liquid Supplements

Intervention will measure strength pre & post operatively. Intervention group will receive liquid supplements (3oz daily shots) pre (Prepare) and Post (Recover) operatively.

Dietary Supplement: - Non-Supplementation Group

Intervention will measure strength pre & post operatively. Intervention group will not receive liquid supplements.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

University Orthopedics Center, Altoona, Pennsylvania

Status

Recruiting

Address

University Orthopedics Center

Altoona, Pennsylvania, 16602

Site Contact

Tara M

[email protected]

814-231-2101